Skip to main content

FDA Approvals

FDA Approvals, Oncology Overview, Payers' Guide, Oncology
New Indications Approved by the FDA in 2018 for Oncology Drugs
Dalia Buffery, MA, ABD
Read More
Breast Cancer, FDA Approvals, In the News, Oncology
FDA Approves First Hormonal-Based Therapy for Men with Advanced or Metastatic Breast Cancer
Read More
Breast Cancer, FDA Approvals, In the News, Oncology
Proposed Landmark Policy Changes to Modernize Mammography and Raise Breast Density Awareness
Read More
FDA Approvals, In the News, Lung Cancer, Oncology
FDA Approves Tecentriq plus Chemotherapy for First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer
Read More
FDA Approvals, In the News
FDA Approves Tecentriq plus Abraxane—First Immunotherapy for PD-L1– Positive Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer
Read More
FDA Approvals, In the News
March 08, 2019 - FDA Approvals, News & Updates
Read More
FDA Approvals
Dual-Specific CAR T-Cell Therapy Targets CD19 and CD22 in Patients with Acute Lymphoblastic Leukemia
Chase Doyle
Chase Doyle
Read More
FDA Approvals
AMG 420, a Novel BiTE, Shows Impressive Responses in Heavily Treated Patients with Multiple Myeloma
Wayne Kuznar
Wayne Kuznar
Read More
FDA Approvals
Selinexor a Promising Oral Option in Triple-Class Refractory Multiple Myeloma
Wayne Kuznar
Wayne Kuznar
Read More
FDA Approvals, In the News
FDA Approves Pembrolizumab for Treatment of Advanced Melanoma
Read More
Page 25 of 53
Results 241 - 250 of 522